Advances in the management of Hodgkin's and non-Hodgkin's lymphoma.
Recent developments in the management of lymphoma continue to refine our approach to the disease. There is increasing acceptance of the International Lymphoma Study Group classification for non-Hodgkin's lymphoma. Identification of a new viral agent associated with certain subtypes of lymphoma and new immunologic therapies change our perspective on the disease. New data on treatment results further elucidate the role of radiotherapy and high-dose therapy in Hodgkin's disease and the non-Hodgkin's lymphomas.
Davis
T A
TA
Division of Medical Oncology, Stanford University Medical Center, CA 94305, USA.
Horning
S J
SJ
D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy* / Q000821:virology; D011878:Radiotherapy / Q000639:trends